VisReed
← All technology

PeriVision VisionOne

PeriVision VisionOne

Abstract

PeriVision VisionOne™ is a VR-based visual field testing platform for glaucoma diagnosis and monitoring.

Clinical Performance Statistics:

Accuracy & Reliability:

  • Correlation with gold standard (Dynamic Strategy): r = 0.927, p < 0.001
  • Test-retest variability: 1.30 dB (compared to 1.71 dB for SITA standard)
  • Reduction in inter-test variability: 26-39%
  • Clinical decision agreement: Equal to Dynamic Strategy, with better agreement between SORS and DS than between different human assessors on DS alone

Device Specifications:

Hardware:

  • Weight: 0.6 kg (portable)
  • Form factor: VR headset
  • Test duration: ~5 minutes
  • Operation: Software subscription model, requires no dedicated testing room or assistant

Clinical Benefits:

Efficiency Gains:

  • 63% reduction in technician time compared to conventional visual field testing
  • 21-30% increase in potential patient volume (median estimate from eye doctors in market survey)
  • 100% flexibility - can be used anywhere in the practice
  • 95% of patients found the system easy to use

Key Advantages Over Conventional Perimetry:

  • Portable (vs. stationary equipment)
  • Cost-efficient (no dedicated room, no assistant needed)
  • Better data reliability (26-38% less variability)
  • Higher patient comfort
  • Intuitive dashboard for both technicians and clinicians

Technology:

  • Combines patented AI algorithms
  • VR technology for immersive testing
  • Cloud-based platform with separate technician and clinician dashboards
  • Swiss engineering
  • Internationally clinically validated

The system represents a significant advancement over traditional Humphrey visual field analyzers, offering comparable accuracy with much better portability, efficiency, and patient experience.

Visreed